---
title: "CRISPR Therapeutics AG Stock 12‑Month Price Target Cut to $81.1, Implies 64% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289425176.md"
description: "CRISPR Therapeutics AG's average 12-month price target was lowered from $82.15 to $81.1 by 21 analysts, implying a 64% upside from the June 10 close. Despite the cut, the consensus rating remains 'Buy' among 26 covering analysts, with 15 buys and 11 holds."
datetime: "2026-06-11T07:20:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289425176.md)
  - [en](https://longbridge.com/en/news/289425176.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289425176.md)
generator: "portal-rs"
---

# CRISPR Therapeutics AG Stock 12‑Month Price Target Cut to $81.1, Implies 64% Upside

-   According to estimates from 21 analysts, CRISPR Therapeutics AG stock's average price target has fallen from $82.15 to $81.1, with forecasts ranging from $44 to $291 per share
-   Based on the Jun. 10 closing price, the updated target implies approximately 64% potential upside
-   Consensus rating remains at “Buy” across 26 covering analysts, with 15 Buys, 11 Holds and 0 Sells

Explore more price target data and ratings for CRISPR Therapeutics AG on the , and track all previous and future analyst recommendations for CRISPR Therapeutics AG in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [CRSP.US](https://longbridge.com/en/quote/CRSP.US.md)

## Related News & Research

- [CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data](https://longbridge.com/en/news/297413766.md)
- [CRISPR Therapeutics (NASDAQ:CRSP) Earns Market Outperform Rating from Citizens Jmp](https://longbridge.com/en/news/296922645.md)
- [What Are Wall Street Analysts' Target Price for Packaging Corporation of America Stock?](https://longbridge.com/en/news/297044621.md)
- [20:15 ETAEVEX Corp. (AVEX) Class Action Lawsuit: Investors Face October 20, 2026, Deadline](https://longbridge.com/en/news/297410050.md)
- [Keep This Renewable Energy Stock Close Until November](https://longbridge.com/en/news/296821932.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**